[1]Chen WJ, Yin K, Zhao GJ, et al. The magic and mystery of microRNA-27 in atherosclerosis[J]. Atherosclerosis, 2012, 222(2):314-323.
[2]Polyakova EA, Zaraiskii MI, Mikhaylov EN, et al. Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: a cross-sectional study[J]. Int J Cardiol, 2021, 322:9-15.
[3]Wang J, Song Y, Zhang Y, et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice[J]. Cell Res, 2012, 22(3):516-527.
[4]Xiang JF, Yu JC, Zhu JY. Up-regulation of miR-27 extenuates lipopolysaccharide-induced injury in H9c2 cells via modulating ICAM1 expression[J]. Genes Genomics, 2019, 41(12):1467-1474.
[5]Zhou YZ, Li SH, Chen P, et al. MicroRNA-27b-3p inhibits apoptosis of chondrocyte in rheumatoid arthritis by targeting HIPK2[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):1766-1771.
[6]Liu F, Zhang S, Zhao Z, et al. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer[J]. Oncotarget, 2016, 7(15):19666-19679.
[7]Li S, Zhu Z, Xue M, et al. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(6):1241-1252.
[8]Li XY, Le HT, Sato F, et al. Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy[J]. Biochem Biophys Res Commun, 2020, 532(4):513-519.
[9]Zhang XN, Dong SY, Jia QJ, et al. The microRNA in ventricular remodeling: the miR-30 family[J]. Biosci Rep, 2019, 39(8):BSR20190788.
[10] Zhang J, Cao Z, Yang G, et al. MicroRNA-27a (miR-27a) in solid tumors: a review based on mechanisms and clinical observations[J]. Front Oncol, 2019, 9:893.
[11] Ding L, Ni J, Yang F, et al. Promising therapeutic role of miR-27b in tumor[J]. Tumour Biol, 2017, 39(3):1010428317691657.
[12] Zhang M, Cheng K, Chen H, et al. MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3[J]. Arch Biochem Biophys, 2020, 689:108405.
[13] Zhang XL, An BF, Zhang GC. MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-κB pathway[J]. Kaohsiung J Med Sci, 2019, 35(10):607-614.